InMed Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
InMed Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • InMed Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 20, 2024 was 13.3M shares, a 301% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 13.3M +10M +301% Sep 20, 2024 10-K 2024-09-30
Q4 2023 6.06M Feb 13, 2024 10-Q 2024-02-13
Q3 2023 3.33M +2.42M +266% Sep 29, 2023 10-K/A 2023-12-21
Q1 2023 3.33M -11.3M -77.3% Feb 17, 2023 10-Q 2023-02-17
Q3 2022 909K -8.47M -90.3% Sep 23, 2022 10-K/A 2022-09-28
Q1 2022 14.6M +6.59M +81.9% May 13, 2022 10-Q 2022-05-13
Q4 2021 14.1M +7.14M +102% Feb 14, 2022 10-Q 2022-02-14
Q3 2021 9.38M Sep 24, 2021 10-K 2021-09-24
Q1 2021 8.05M May 13, 2021 10-Q 2021-05-13
Q4 2020 7M Dec 15, 2020 10-Q 2020-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.